Sign in

CIK 0001472091

  • Non-accelerated filer
  • Smaller reporting company

PDS Biotechnology Corp

Sign in to watch
Ticker
PDSB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
264231384
Phone
+1 800-208-3343
Business address
303A COLLEGE ROAD EAST, PRINCETON, NJ, 08540
Former names
Edge Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2018-03-01 Saik Andrew Chief Financial Officer Grant or award · Stock Option (Right To Purchase) +50,000 50,000
2018-03-01 Wyant Alyssa SVP Regulatory Affairs Grant or award · Stock Option (Right To Purchase) +50,000 50,000
2018-03-01 MARCHIO ALBERT N II Chief Accounting & Adm Officer Grant or award · Stock Option (Right To Purchase) +25,000 25,000
2018-03-01 Leuthner Brian A President and CEO Sale −2,500 $14.81 $37K 72,736
2018-03-01 Leuthner Brian A President and CEO Grant or award · Stock Option (Right To Purchase) +280,000 280,000
2018-02-23 Leuthner Brian A President and CEO Sale −2,500 $15.37 $38K 75,236
2018-02-22 Leuthner Brian A President and CEO Sale −2,500 $15.47 $39K 77,736
2018-02-22 Macdonald R. Loch Chief Scientific Officer Sale −2,500 $14.49 $36K 583,102
2018-02-21 Macdonald R. Loch Chief Scientific Officer Sale −5,000 $13.82 $69K 585,602
2018-02-20 Macdonald R. Loch Chief Scientific Officer Sale −5,000 $13.75 $69K 590,602
2018-02-02 Leuthner Brian A President and CEO Sale −2,500 $12.96 $32K 80,236
2018-02-01 Leuthner Brian A President and CEO Sale −2,500 $13.14 $33K 82,736
2018-01-03 Leuthner Brian A President and CEO Sale −2,500 $10.11 $25K 85,236
2018-01-02 Faleck Herbert J Chief Medical Officer Grant or award · Stock Option (Right To Purchase) +50,000 50,000
2018-01-02 MARCHIO ALBERT N II Chief Accounting & Adm Officer Grant or award · Stock Option (Right To Purchase) +50,000 50,000
2018-01-02 Leuthner Brian A President and CEO Sale −2,500 $10.11 $25K 87,736
2017-12-05 Leuthner Brian A President and CEO Sale −2,500 $9.68 $24K 90,236
2017-12-04 Leuthner Brian A President and CEO Sale −2,500 $9.97 $25K 92,736
2017-12-01 Leuthner Brian A President and CEO Sale −2,500 $9.92 $25K 95,236
2017-11-22 MARCHIO ALBERT N II Chief Accounting & Adm Officer Sale −3,361 $10.00 $34K 0

Page 10 of 18 · 346 trades